Association between papillary thyroid cancer and XRCC6 gene polymorphisms in the Turkish population
Turkish Journal of Medical Sciences · 01.01.2024 · 54 (6) · 1215-1222
DOI: 10.55730/1300-0144.5902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2024. Verfasst von Egemen Akgün und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkiye. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Thyroid Cancer, Papillary, Thyroid Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: This study aims to investigate the association between rs2267437, rs5751129 and rs132770 polymorphisms of the XRCC6 gene, which plays a role in repairing DNA double strand breaks, and the risk of Papillary Thyroid Cancer (PTC).
Methods
The study included 150 patients who had been diagnosed with PTC and 204 healthy control subjects. Genotyping of SNPs was performed by Polymerase Chain Reaction - Restriction Fragment Length Polymorphism method (PCR - RFLP).
Results
In rs2267437 polymorphism, individuals with GG genotype had lower risk of PTC than wild-type CC genotype (p=0.037, 95% CI=0.19-0.96, OR=0.67). The combined genotypes CG+GG were found to be related to a reduced risk of PTC compared to the wild-type CC (p=0.023, 95% CI=0.40-0.94, OR=0.61) in the recessive model (GC+GG vs. CC). In addition, a query of the Genotype-Tissue Expression (GTEx) database showed that the rs2267437 polymorphism may alter the expression level of XRCC6 in whole blood (p=0.0009) but not in thyroid tissue. There were no significant association of rs5751129 and rs132770 polymorphisms with PTC.
Conclusion
In conclusion, this study demonstrated that rs2267437 polymorphism may have a protective effect against PTC in the Turkish population. However, rs5751129 and rs132770 polymorphisms were not associated with the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkiye.
- Department of Medical Genetics, Faculty of Medicine, Giresun University, Giresun, Turkiye.
- Department of Pathology, Faculty of Medicine, Giresun University, Giresun, Turkiye.
- Department of Physiology, Faculty of Medicine, Giresun University, Giresun, Turkiye.
- Giresun University Faculty of Health Sciences, Giresun, Turkiye.
- Department of General Surgery, Faculty of Medicine, Giresun University, Giresun, Turkiye.
ORCID-Profile: Egemen Akgün, Fadime Mutlu Içduygu, Demet Şengül, Ebru Alp, Mehmet Alkanat, Ayşegül Çebi, Tuncer Öztürk
Zitieren
APA
Akgün, E., Mutlu Içduygu, F., Şengül, D., Alp, E., Alkanat, M., Çebi, A., & Öztürk, T. (2024). Association between papillary thyroid cancer and XRCC6 gene polymorphisms in the Turkish population. Turkish Journal of Medical Sciences, 54(6), 1215-1222. https://doi.org/10.55730/1300-0144.5902
Vancouver
Akgün E, Mutlu Içduygu F, Şengül D, Alp E, Alkanat M, Çebi A, et al. Association between papillary thyroid cancer and XRCC6 gene polymorphisms in the Turkish population. Turkish Journal of Medical Sciences. 2024;54(6):1215-1222. doi:10.55730/1300-0144.5902
BibTeX
@article{Akgn2024,
author = {Akgün, Egemen and Mutlu Içduygu, Fadime and Şengül, Demet and Alp, Ebru and Alkanat, Mehmet and Çebi, Ayşegül and Öztürk, Tuncer},
title = {Association between papillary thyroid cancer and XRCC6 gene polymorphisms in the Turkish population},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {6},
pages = {1215--1222},
doi = {10.55730/1300-0144.5902}
}
EUVIMED